Menu
Back to User profile » Dr Jinming Yu
Papers published by Dr Jinming Yu:
Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib Plus Humanized Programmed Death Receptor-1 in Patients with High-Risk Advanced Hepatocellular Carcinoma: A Real-World Study
Chang X, Wu H, Ning S, Li X, Xie Y, Shao W, Yu J
Journal of Hepatocellular Carcinoma 2023, 10:1497-1509
Published Date: 6 September 2023
Estimating Survival in Patients with Non-Small-Cell Lung Cancer and Brain Metastases: A Verification of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)
Li J, Jing W, Zhai X, Jia W, Zhu H, Yu J
OncoTargets and Therapy 2021, 14:1623-1631
Published Date: 2 March 2021
Use of Chemoradiotherapy as a Treatment Option for Patients with Limited-Stage Primary Small Cell Carcinoma of the Esophagus
Zhao K, Huang Z, Si Y, Sun L, Yu J, Meng X
Cancer Management and Research 2021, 13:613-623
Published Date: 25 January 2021
Timing of Adjuvant Chemoradiation in pT1-3N1-2 or pT4aN1 Esophageal Squamous Cell Carcinoma After R0 Esophagectomy
Wu L, Zhang Z, Li S, Ke L, Yu J, Meng X
Cancer Management and Research 2020, 12:10573-10585
Published Date: 27 October 2020
Application and Prospects of Molecular Imaging in Immunotherapy
Wang W, Gao Z, Wang L, Li J, Yu J, Han S, Meng X
Cancer Management and Research 2020, 12:9389-9403
Published Date: 30 September 2020
Prognostic Value of a Nomogram Based on the Dynamic Albumin-to-Alkaline Phosphatase Ratio for Patients with Extensive-Stage Small-Cell Lung Cancer
Li B, Jiang C, Wang R, Zou B, Xie P, Li W, Sun X, Yu J, Wang L
OncoTargets and Therapy 2020, 13:9043-9057
Published Date: 11 September 2020
Research Progress and Existing Problems for Abscopal Effect
Wang D, Zhang X, Gao Y, Cui X, Yang Y, Mao W, Li M, Zhang B, Yu J
Cancer Management and Research 2020, 12:6695-6706
Published Date: 3 August 2020
Clinical Applications of Cerebrospinal Fluid Circulating Tumor DNA as a Liquid Biopsy for Central Nervous System Tumors
Yan W, Xu T, Zhu H, Yu J
OncoTargets and Therapy 2020, 13:719-731
Published Date: 23 January 2020
Radiotherapy for patients with completely resected pathologic IIIA(N2) non–small-cell lung cancer: a retrospective analysis
Zhu Y, Fu L, Jing W, Kong L, Yu J
Cancer Management and Research 2019, 11:10901-10908
Published Date: 31 December 2019
Bevacizumab in Combination with Pemetrexed and Platinum Significantly Improved the Clinical Outcome of Patients with Advanced Adenocarcinoma NSCLC and Brain Metastases
Tian Y, Zhai X, Tian H, Jing W, Zhu H, Yu J
Cancer Management and Research 2019, 11:10083-10092
Published Date: 29 November 2019
Temozolomide Combined With Capecitabine In The Treatment Of Mixed Neuroendocrine Carcinoma Of The Lung With Poor Tolerance After Repeated Radiochemotherapy: A Case Report And Literature Review
Zhang B, Wang D, Zhang X, Cui X, Kong L, Li M, Yu J
OncoTargets and Therapy 2019, 12:9663-9668
Published Date: 14 November 2019
Ten-Year Outcomes Of Intensity-Modulated Radiotherapy (IMRT) Combine With Chemotherapy Versus IMRT Alone For Stage II Nasopharyngeal Carcinoma In The Real-World Study (RWD)
Ding XC, Fan PP, Xie P, Fan BJ, Yang J, Jiang LY, Bai XB, Yu JM, Hu M
Cancer Management and Research 2019, 11:8893-8903
Published Date: 10 October 2019
Therapeutic Effect Of First-Line EGFR-TKIs Combined With Concurrent Cranial Radiotherapy On NSCLC Patients With EGFR Activating Mutation And Brain Metastasis: A Retrospective Study
An N, Wang H, Li J, Zhai X, Jing W, Jia W, Kong L, Zhu H, Yu J
OncoTargets and Therapy 2019, 12:8311-8318
Published Date: 8 October 2019
Great efficacy of afatinib on a patient with lung adenocarcinoma harboring uncommon EGFR delE709_T710insD mutations: a case report
An N, Wang H, Zhu H, Yan W, Jing W, Kong L, Zhang Y, Yu J
OncoTargets and Therapy 2019, 12:7399-7404
Published Date: 10 September 2019
Expression and prognostic role of IKBKE and TBK1 in stage I non-small cell lung cancer
Wang X, Teng F, Lu J, Mu D, Zhang J, Yu J
Cancer Management and Research 2019, 11:6593-6602
Published Date: 15 July 2019
Increased systemic immune-inflammation index independently predicts poor survival for hormone receptor-negative, HER2-positive breast cancer patients
Sun Y, Li W, Li AJ, Su H, Yue J, Yu J
Cancer Management and Research 2019, 11:3153-3162
Published Date: 11 April 2019
Primary tumor location is an important predictor of survival in pulmonary adenocarcinoma
Wang Z, Li M, Teng F, Kong L, Yu J
Cancer Management and Research 2019, 11:2269-2280
Published Date: 21 March 2019
Axillary management still needed for patients with sentinel node micrometastases
Cong BB, Yu JM, Wang YS
Cancer Management and Research 2019, 11:2097-2100
Published Date: 8 March 2019
Surgery of primary tumor improves the survival of newly diagnosed metastatic melanoma: a population-based, propensity-matched study
Zhang D, Dong Y, Sun X, Yuan S, Yu J
Cancer Management and Research 2019, 11:339-346
Published Date: 27 December 2018
Local ablative therapy with or without chemotherapy for non-small-cell lung cancer patients with postoperative oligometastases
Shang S, Su Y, Zhu Z, Li B, Guo M, Xu Y, Sun X, Wang L, Yu J
Cancer Management and Research 2018, 10:6421-6429
Published Date: 27 November 2018
Predictive value of LDH kinetics in bevacizumab treatment and survival of patients with advanced NSCLC
Li B, Li C, Guo M, Shang S, Li X, Xie P, Sun X, Yu J, Wang L
OncoTargets and Therapy 2018, 11:6287-6294
Published Date: 27 September 2018
Clinical value of carcinoembryonic antigen for predicting the incidence of brain metastases and survival in small cell lung cancer patients treated with prophylactic cranial irradiation
Guo D, Jing W, Zhu H, Li MH, Zou B, Zhang Y, Fu L, Kong L, Yue J, Yu J
Cancer Management and Research 2018, 10:3199-3205
Published Date: 4 September 2018
18F-fluorodeoxyglucose positron emission tomography predicts lymph node responses to definitive chemoradiotherapy in esophageal squamous cell carcinoma patients
Zhu W, Zhang Y, Kong L, Huang Y, Zheng J, Wang R, Li M, Yu J
OncoTargets and Therapy 2018, 11:4345-4353
Published Date: 25 July 2018
A prospective study on neoadjuvant chemoradiotherapy plus anti-EGFR monoclonal antibody followed by surgery for locally advanced cervical cancer
Lu H, Wu Y, Liu X, Jiang H, Pang Q, Peng L, Cheng J, Deng S, Gu J, Zhao R, Hu X, Chen C, Yu J
OncoTargets and Therapy 2018, 11:3785-3792
Published Date: 2 July 2018
Clinical and radiological characteristics of central pulmonary adenocarcinoma: a comparison with central squamous cell carcinoma and small cell lung cancer and the impact on treatment response
Wang Z, Li M, Huang Y, Ma L, Zhu H, Kong L, Yu J
OncoTargets and Therapy 2018, 11:2509-2517
Published Date: 4 May 2018
Radiotherapy for esophageal carcinoma: dose, response and survival
Luo Y, Mao Q, Wang X, Yu J, Li M
Cancer Management and Research 2018, 10:13-21
Published Date: 29 December 2017
Unusual delayed presentation of diaphragmatic hernia complicated by transverse colon and total small-bowel obstruction after postoperative chemotherapy of esophageal cancer
Sun Y, Yin L, Xue H, Wang H, Li Z, Yu J
Therapeutics and Clinical Risk Management 2017, 13:691-695
Published Date: 6 June 2017
The prognostic value of nodal skip metastasis in resectable thoracic esophageal squamous cell carcinoma
Song G, Jing W, Xue S, Guo H, Yu J
OncoTargets and Therapy 2017, 10:2729-2736
Published Date: 25 May 2017
The lymphocyte–monocyte ratio predicts tumor response and survival in patients with locally advanced esophageal cancer who received definitive chemoradiotherapy
Liu X, Li M, Zhao F, Zhu Y, Luo Y, Kong L, Zhu H, Zhang Y, Shi F, Yu J
OncoTargets and Therapy 2017, 10:871-877
Published Date: 14 February 2017
The association of HMGB1 expression with clinicopathological significance and prognosis in Asian patients with colorectal carcinoma: a meta-analysis and literature review
Zhang XL, Yu JM, Li MH, Zhu H, Sun XD, Kong L
OncoTargets and Therapy 2016, 9:4901-4911
Published Date: 8 August 2016
Details of out-field regional recurrence after involved-field irradiation with concurrent chemotherapy for locally advanced esophageal squamous cell carcinoma
Zhang X, Yu J, Li M, Zhu H
OncoTargets and Therapy 2016, 9:3049-3057
Published Date: 23 May 2016
Potential impact of 18FDG-PET/CT on surgical approach for operable squamous cell cancer of middle-to-lower esophagus
Liu S, Zhu H, Li W, Zhang B, Ma L, Guo Z, Huang Y, Song P, Yu J, Guo H
OncoTargets and Therapy 2016, 9:855-862
Published Date: 22 February 2016
Sustained response of malignant pericardial effusion to intrapericardial bevacizumab in an advanced lung cancer patient: a case report and literature review
Chen DW, Zhang Y, Shi F, Li MH, Zhu H, Kong L, Yu JM
OncoTargets and Therapy 2015, 8:2767-2770
Published Date: 1 October 2015
A spectrum of cutaneous toxicities from erlotinib may be a robust clinical marker for non-small-cell lung therapy: a case report and literature review
Jin F, Zhu H, Kong L, Yu JM
OncoTargets and Therapy 2015, 8:943-946
Published Date: 23 April 2015